1. In Vitro Antitrypanosomal Activity of the Secondary Metabolites from the Mutant Strain IU-3 of the Insect Pathogenic Fungus Ophiocordyceps coccidiicola NBRC 100683
- Author
-
Toshihiro Hashimoto, Kanako Iseki, Kento Yoshii, Akemi Umeyama, Kazuhiko Otoguro, Masaaki Noji, Sayaka Ban, Aki Ishiyama, Yuuta Ōtsuki, Rei Hokari, Masato Iwatsuki, Momoko Ganaha, Miki Iguchi, Satoshi Ōmura, and Yasuko Okamoto
- Subjects
0301 basic medicine ,Depsipeptide ,biology ,010405 organic chemistry ,Chemistry ,media_common.quotation_subject ,General Chemistry ,General Medicine ,Ophiocordyceps ,Insect ,Pathogenic fungus ,Trypanosoma brucei ,biology.organism_classification ,01 natural sciences ,In vitro ,0104 chemical sciences ,Microbiology ,03 medical and health sciences ,030104 developmental biology ,Mutant strain ,Drug Discovery ,Structure–activity relationship ,media_common - Abstract
During the search for new antitrypanosomal drug leads, four antitrypanosomal compounds, of three depsipeptides and one nortriterpenoid, were isolated from cultures of the mutant strain IU-3 of the insect pathogenic fungus Ophiocordyceps coccidiicola NBRC 100683. Their structures were identified by the analysis of high resolution-electron ionization (HR-EI)-MS and HR-FAB-MS, and (1)H- and (13)C-NMR spectra, including extensive two dimensional (2D)-heteronuclear NMR experiments, and comparison with literature data for destruxin A (1), destruxin B (2), destruxin E chlorohydrin (3) and helvolic acid (4). Compounds 1-4 showed in vitro antitrypanosomal activity against Trypanosoma brucei brucei GUTat3.1 with IC50 values of 0.33, 0.16, 0.061 and 5.08 µg/mL, respectively.
- Published
- 2016
- Full Text
- View/download PDF